FDA, India collaborate to stop unapproved medical products

The Food and Drug Administration, in its first enforcement operation with the government of India, recently stopped about 500 shipments of unapproved prescription drugs and combination medical devices from reaching U.S. consumers, the agency announced today. The shipments, many sent through third-party countries to conceal their origin, included about 50 FDA-regulated products, including cancer and HIV medications and opioid products, FDA said. “Consumers and physicians purchasing medicines cannot be assured the products they are receiving are legitimate, safe or effective if they are obtained from outside of the FDA-regulated pharmaceutical supply chain,” said FDA Commissioner Stephen Hahn, M.D.
Related News Articles
Headline
President Trump July 7 issued an executive order, “Extending the Modification of the Reciprocal Tariff Rates,” which extends the original July 9 reciprocal…
Headline
The AHA submitted a statement today to the House Energy and Commerce Subcommittee on Health for a hearing today on the health care supply chain. The AHA…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an…
Headline
The U.S. Court of International Trade May 28 blocked a series of tariffs issued by the Trump administration under the International Emergency Economic Powers…
Chairperson's File
We are all closely watching changing tariff policy as it raises serious considerations for the medical products, devices and pharmaceuticals supply chain. Our…
Chairperson's File
Most hospitals and health systems are the largest organizations in our communities, providing critical services needed by every one of our neighbors. We take…